Home » Topics » BioWorld Science

BioWorld Science
RSS

XMT-1522 demonstrates safety and preliminary efficacy in phase I study

June 19, 2018

Roche and Foundation Medicine enter definitive merger agreement

June 19, 2018

FDA removes clinical hold on IGNITE DMD study of SGT-001

June 19, 2018

Sanofi completes acquisition of Ablynx

June 19, 2018

Clover initiates phase I trial of SCB-313 for malignant ascites

June 19, 2018

Cognition Therapeutics initiates SPARC trial of Elayta in Alzheimer's disease

June 19, 2018

MXRA8, a drug-targetable receptor for chikunguya and other arthritogenic alphaviruses

June 19, 2018

Rhythm announces new topline clinical data for setmelanotide in rare genetic disorders of obesity

June 19, 2018

Agios initiates phase III ACTIVATE study of AG-348 in pyruvate kinase deficiency

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026